1286 related articles for article (PubMed ID: 11731664)
1. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
Kappas A; Drummond GS; Munson DP; Marshall JR
Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
[TBL] [Abstract][Full Text] [Related]
2. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
Valaes T; Drummond GS; Kappas A
Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
[TBL] [Abstract][Full Text] [Related]
3. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.
Martinez JC; Garcia HO; Otheguy LE; Drummond GS; Kappas A
Pediatrics; 1999 Jan; 103(1):1-5. PubMed ID: 9917431
[TBL] [Abstract][Full Text] [Related]
4. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
Kappas A; Drummond GS; Valaes T
Pediatrics; 2001 Jul; 108(1):25-30. PubMed ID: 11433050
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
Kappas A; Drummond GS; Henschke C; Valaes T
Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
[TBL] [Abstract][Full Text] [Related]
6. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
[TBL] [Abstract][Full Text] [Related]
7. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
[TBL] [Abstract][Full Text] [Related]
8. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
Suresh GK; Martin CL; Soll RF
Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
[TBL] [Abstract][Full Text] [Related]
9. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.
Maisels MJ; Yang H
J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.
Bhutani VK; Poland R; Meloy LD; Hegyi T; Fanaroff AA; Maisels MJ
J Perinatol; 2016 Jul; 36(7):533-9. PubMed ID: 26938918
[TBL] [Abstract][Full Text] [Related]
11. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
12. Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease.
Rosenfeld WN; Hudak ML; Ruiz N; Gautam S;
J Perinatol; 2022 Jan; 42(1):110-115. PubMed ID: 34635771
[TBL] [Abstract][Full Text] [Related]
13. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
[TBL] [Abstract][Full Text] [Related]
14. Tin-metalloporphyrins: an answer to neonatal jaundice?
Steffensrud S
Neonatal Netw; 1998 Aug; 17(5):11-7; quiz 18-9. PubMed ID: 9791442
[TBL] [Abstract][Full Text] [Related]
15. Metalloporphyrins in the management of neonatal hyperbilirubinemia.
Stevenson DK; Wong RJ
Semin Fetal Neonatal Med; 2010 Jun; 15(3):164-8. PubMed ID: 20006567
[TBL] [Abstract][Full Text] [Related]
16. Cochrane Review: Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.
Okwundu CI; Okoromah CA; Shah PS
Evid Based Child Health; 2013 Jan; 8(1):204-49. PubMed ID: 23878128
[TBL] [Abstract][Full Text] [Related]
17. Clinical rounds in the well-baby nursery: treating jaundiced newborns.
Maisels MJ
Pediatr Ann; 1995 Oct; 24(10):547-52. PubMed ID: 8545162
[TBL] [Abstract][Full Text] [Related]
18. Double phototherapy in jaundiced term infants with hemolysis.
Thaithumyanon P; Visutiratmanee C
J Med Assoc Thai; 2002 Nov; 85(11):1176-81. PubMed ID: 12546314
[TBL] [Abstract][Full Text] [Related]
19. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
Drummond GS; Kappas A
Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
